3 news items
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
VXRT
13 Jun 24
to develop new, innovative vaccines and therapeutics that provide broader and more durable protection against COVID-19 than the first generation COVID-19
Palo Alto Networks Shares Drop After Q3 Results, In-Line Guidance: The Details
PANW
VXRT
20 May 24
while investing in go-to-market and innovation,” said Dipak Golechha, chief financial officer of Palo Alto Networks. “We
Vaxart Announces Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers; Long-Term Goal Is To Provide Protection To Infants Through Passive Antibody Transfer
VXRT
30 Apr 24
developing. Passive transfer of antibodies from mothers to infants via breast milk is an innovative approach to potentially improve infection
- Prev
- 1
- Next